Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men

Journal of Infectious Diseases

Volumn 195, Issue 1, 2007, Pages 30-36

  Casper, Corey ^a,b   Krantz, Elizabeth ^a   Selke, Stacy ^a   Kuntz, Steven R ^a   Wang, Jie ^a   Huang, Meei Li ^a   Pauk, John S ^c   Corey, Lawrence ^a,b   Wald, Anna ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Polyclinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DNA DETERMINATION; HETEROSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOCOMPETENCE; MALE; OROPHARYNX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; SYMPTOMATOLOGY; VIRUS INFECTION; VIRUS SHEDDING;

ADULT; AGED; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HOMOSEXUALITY; HUMANS; IMMUNOCOMPETENCE; MALE; MIDDLE AGED; MOUTH; OROPHARYNX; PROSPECTIVE STUDIES; SEXUAL BEHAVIOR; VIRUS SHEDDING;

EID: 33845621583     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/509621     Document Type: Article

References (46)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
2. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000; 342:1027-38.
3. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770-5.
4. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest 1997; 99:1092-7.
5. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844-50.
6. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:3100-6.
7. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20.
8. Wald A, Ericsson M, Krantz E, Selke S, Corey L. Oral shedding of herpes simplex virus type 2. Sex Transm Infect 2004; 80:272-6.
9. Balfour HH Jr, Holman CJ, Hokanson KM, et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis 2005; 192:1505-12.
10. Fafi-Kremer S, Morand P, Germi R, et al. A prospective follow-up of Epstein-Barr virus LMP1 genotypes in saliva and blood during infectious mononucleosis. J Infect Dis 2005; 192:2108-11.
11. Handsfield HH, Chandler SH, Caine VA, et al. Cytomegalovirus infection in sex partners: evidence for sexual transmission. J Infect Dis 1985; 151:344-8.
12. Klemola E, von Essen R, Wager O, Haltia K, Koivuniemi A, Salmi I. Cytomegalovirus mononucleosis in previously healthy individuals: five new cases and follow-up of 13 previously published cases. Ann Intern Med 1969; 71:11-9.
13. Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352:768-76.
14. Pauk J, Huang ML, Brodie SJ, et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000; 343:1369-77.
15. Taylor MM, Chohan B, Lavreys L, et al. Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. J Infect Dis 2004; 190:484-8.
16. Vieira J, Huang ML, Koelle DM, Corey L. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 1997; 71:7083-7.
17. Casper C, Carrell D, Miller KG, et al. HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men-baseline data from the EXPLORE study. Sex Transm Infect 2006; 82:229-35.
18. Casper C, Krantz E, Taylor H, et al. Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection. J Clin Microbiol 2002; 40:3822-5.
19. Ryncarz AJ, Goddard J, Wald A, Huang ML, Roizman B, Corey L. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol 1999; 37:1941-7.
20. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6:986-94.
21. Koelle DM, Huang M-L, Chandran B, Vieira J, Piepkorn M, Corey L. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 1997; 176:94-102.
22. Zerr DM, Huang ML, Corey L, Erickson M, Parker HL, Frenkel LM. Sensitive method for detection of human herpesviruses 6 and 7 in saliva collected in field studies. J Clin Microbiol 2000; 38:1981-3.
23. Casper C, Nichols WG, Huang ML, Corey L, Wald A. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 2004; 103:1632-4.
24. Hall DB. Zero-inflated Poisson and binomial regression with random effects: a case study. Biometrics 2000; 56:1030-9.
25. Duus KM, Lentchitsky V, Wagenaar T, Grose C, Webster-Cyriaque J. Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J Virol 2004; 78:4074-84.
26. Lucht E, Brytting M, Bjerregaard L, Julander I, Linde A. Shedding of Cytomegalovirus and herpesviruses 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infected patients and healthy controls. Clin Infect Dis 1998; 27:137-41.
27. Cattani P, Capuano M, Cerimele F, et al. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol 1999; 37:1150-3.
28. Vitale F, Viviano E, Perna AM, et al. Serological and virological evidence of non-sexual transmission of human herpesvirus type 8 (HHV8). Epidemiol Infect 2000; 125:671-5.
29. Mbulaiteye SM, Pfeiffer RM, Engels EA, et al. Detection of Kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis 2004; 190:1382-6.
30. Andreoni M, Sarmati L, Nicastri E, et al. Primary human herpesvirus 8 infection in immunocompetent children. JAMA 2002; 287:1295-300.
31. Luppi M, Barozzi P, Schulz TF, et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 2000; 343:1378-85.
32. Luppi M, Barozzi P, Rasini V, et al. Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation 2002; 74:131-2.
33. + T-cell response to viral lytic cycle proteins. Blood 2001; 97:2366-73.
34. Sarmati L. Serological testing for human herpesvirus 8. Herpes 2001; 8:76-9.
35. Gerber P, Lucas S, Nonoyama M, Perlin E, Goldstein LI. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 1972; 2:988-9.
36. Heath CW Jr, Brodsky AL, Potolsky AI. Infectious mononucleosis in a general population. Am J Epidemiol 1972; 95:46-52.
37. Dukers NH, Rezza G. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS 2003; 17:1717-30.
38. Casper C, Redman M, Huang ML, et al. HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. J Acquir Immune Defic Syndr 2004; 35:233-8.
39. Schulz TF. Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Adv Cancer Res 1999; 76:121-60.
40. Boivin G, Cote S, Cloutier N, Abed Y, Maguigad M, Routy JP. Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease. J Med Virol 2002; 68:399-403.
41. Cannon MJ, Dollard SC, Black JB, et al. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS 2003; 17:215-22.
42. Engels EA, Biggar RJ, Marshall VA, et al. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 2003; 17:1847-51.
43. Rezza G, Andreoni M, Dorrucci M, et al. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 1999; 91:1468-74.
44. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346:799-802.
45. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94:1204-10.
46. Parkin DM, International Agency for Research on Cancer (IARC). Cancer in Africa: epidemiology and prevention. IARC scientific publications no. 153. Lyon, France: IARC Press, 2003.